AAAAAA
Results:
1-14
|
Results: 14
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
JEWELL L
TAMI JA
BENNETT CF
KISNER DL
SHANAHAN WR
Citation: Br. Yacyshyn et al., A PLACEBO-CONTROLLED TRIAL OF ICAM-1 ANTISENSE OLIGONUCLEOTIDE IN THETREATMENT OF CROHNS-DISEASE, Gastroenterology, 114(6), 1998, pp. 1133-1142
Authors:
BOWENYACYSHYN MB
NATION N
SHANAHAN W
BENNETT F
YACYSHYN BR
Citation: Mb. Bowenyacyshyn et al., ANTISENSE TO ICAM-1 (ISIS-9125) PREVENTS DEVELOPMENT OF INTESTINAL INFLAMMATION IN HLA-B27 TRANSGENIC RATS, Gastroenterology, 114(4), 1998, pp. 3850-3850
Authors:
BOWENYACYSHYN MB
SHANAHAN W
BENNETT F
TAMI J
GALLATIN M
ROTHLEIN B
MAINOLFI E
JEWELL L
YACYSHYN BR
Citation: Mb. Bowenyacyshyn et al., ANTISENSE TO ICAM-1 AFFECTS THE PERIPHERAL-BLOOD EXPRESSION AND INTESTINAL EXPRESSION OF ADHESION MOLECULES IN CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 3851-3851
Authors:
BOWENYACYSHYN MB
YACYSHYN BR
Citation: Mb. Bowenyacyshyn et Br. Yacyshyn, MULTIDRUG-RESISTANT PROTEIN (MRP) EXPRESSION AND FUNCTION IS GREATER IN UC THAN CROHNS-DISEASE IN CONTRAST TO PGP-170, Gastroenterology, 114(4), 1998, pp. 3852-3852
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
TAMI J
SAHBA B
SHANAHAN W
Citation: Br. Yacyshyn et al., SAFETY OF RETREATMENT WITH ANTISENSE TO ICAM-1 (ISIS-2302) IN PATIENTS WITH STEROID-DEPENDENT CROHNS-DISEASE, Gastroenterology, 114(4), 1998, pp. 4574-4574
Authors:
YACYSHYN B
MAKSYMOWYCH W
BOWENYACYSHYN MB
Citation: B. Yacyshyn et al., ULCERATIVE-COLITIS HAS INCREASED PGP-170 EXPRESSION IN CONTRAST TO CROHNS-DISEASE - A POSSIBLE MECHANISM OF CYCLOSPORINE RESISTANCE IN IBD THERAPY, Gastroenterology, 112(4), 1997, pp. 1123-1123
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
PILARSKI LM
Citation: Br. Yacyshyn et al., INHIBITION BY RAPAMYCIN OF P-GLYCOPROTEIN 170-MEDIATED EXPORT FROM NORMAL LYMPHOCYTES, Scandinavian journal of immunology, 43(4), 1996, pp. 449-455
Authors:
YACYSHYN B
MEDDINGS J
SADOWSKI D
BOWENYACYSHYN MB
Citation: B. Yacyshyn et al., MULTIPLE-SCLEROSIS PATIENTS HAVE PERIPHERAL-BLOOD CD45RO-CELLS AND INCREASED INTESTINAL PERMEABILITY( B), Digestive diseases and sciences, 41(12), 1996, pp. 2493-2498
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
Citation: Br. Yacyshyn et Mb. Bowenyacyshyn, INTESTINAL AND PERIPHERAL-BLOOD CD45RO-CELLS AND CD20+ B-CELLS CORRESPONDS WITH CELLULAR APOPTOSIS IN PATIENTS WITH CROHNS-DISEASE AND FIRST DEGREE RELATIVES( EXPRESSION ON CD8+ T), Gastroenterology, 110(4), 1996, pp. 1048-1048
Authors:
YACYSHYN BR
LONGENECKER BM
BIERMANN WA
MCCLURE D
POPPEMA S
BOWENYACYSHYN MB
Citation: Br. Yacyshyn et al., ACTIVE SPECIFIC IMMUNOTHERAPY IN THE MANAGEMENT OF ADENOCARCINOMA OF THE PANCREAS, Canadian journal of gastroenterology, 9(4), 1995, pp. 213-216
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
MEDDINGS J
Citation: Br. Yacyshyn et al., PATIENTS WITH MULTIPLE-SCLEROSIS HAVE INCREASED INTESTINAL PERMEABILITY AND OR EXPRESSION OF CD45RO-CELLS( ON CD19+ B), Gastroenterology, 108(4), 1995, pp. 711-711
Authors:
YACYSHYN BR
BOWENYACYSHYN MB
Citation: Br. Yacyshyn et Mb. Bowenyacyshyn, RAPAMYCIN AND CYCLOSPORINE MEDIATED P-GP INHIBITION IN HUMAN PERIPHERAL-BLOOD LYMPHOCYTES - IMPLICATIONS FOR SOLID-ORGAN TRANSPLANTATION, Gastroenterology, 108(4), 1995, pp. 1202-1202
Authors:
MACLEAN GD
REDDISH MA
BOWENYACYSHYN MB
POPPEMA S
LONGENECKER BM
Citation: Gd. Maclean et al., ACTIVE SPECIFIC IMMUNOTHERAPY AGAINST ADENOCARCINOMAS, Cancer investigation, 12(1), 1994, pp. 46-56
Authors:
YACYSHYN BR
LONGENECKER BM
POPPEMA S
BOWENYACYSHYN MB
Citation: Br. Yacyshyn et al., ACTIVE SPECIFIC IMMUNOTHERAPY FOR PANCREATIC ADENOCARCINOMA, Gastroenterology, 106(4), 1994, pp. 10000452-10000452
Risultati:
1-14
|